RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
4.650
-0.110 (-2.31%)
At close: Oct 6, 2026, 4:00 PM EDT
4.610
-0.040 (-0.86%)
Pre-market: Oct 7, 2026, 4:41 AM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $193.41 million as of October 6, 2026. Its market cap has decreased by -46.28% in one year.
Market Cap
193.41M
Enterprise Value
-4.81M
1-Year Change
-46.28%
Ranking
Category
Stock Price
$4.65
ChartMarket Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $193.41M, a decrease of -54.42%. That is a compound annual growth rate of -14.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 193.41M | -54.86% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Standard BioTools | 292.35M |
| Treace Medical Concepts | 285.50M |
| TriSalus Life Sciences | 266.00M |
| InfuSystem Holdings | 262.11M |
| Electromed | 232.87M |
| Profound Medical | 214.24M |
| Quanterix | 172.15M |
| Neuronetics | 164.59M |